QQQ   368.40 (-1.32%)
AAPL   144.19 (-1.86%)
MSFT   294.31 (-1.68%)
FB   348.40 (-1.29%)
GOOGL   2,807.50 (-1.29%)
TSLA   771.90 (-0.32%)
AMZN   3,349.83 (-2.21%)
NVDA   214.43 (-2.89%)
BABA   145.36 (+0.19%)
NIO   34.91 (-1.33%)
CGC   14.14 (+1.65%)
GE   106.08 (+2.20%)
MU   74.45 (+0.54%)
AMD   103.83 (-1.86%)
T   27.47 (+1.25%)
F   14.13 (+2.54%)
ACB   6.04 (+1.51%)
DIS   176.97 (+0.55%)
PFE   43.77 (-0.39%)
BA   228.34 (+3.14%)
BAC   43.32 (+2.80%)
QQQ   368.40 (-1.32%)
AAPL   144.19 (-1.86%)
MSFT   294.31 (-1.68%)
FB   348.40 (-1.29%)
GOOGL   2,807.50 (-1.29%)
TSLA   771.90 (-0.32%)
AMZN   3,349.83 (-2.21%)
NVDA   214.43 (-2.89%)
BABA   145.36 (+0.19%)
NIO   34.91 (-1.33%)
CGC   14.14 (+1.65%)
GE   106.08 (+2.20%)
MU   74.45 (+0.54%)
AMD   103.83 (-1.86%)
T   27.47 (+1.25%)
F   14.13 (+2.54%)
ACB   6.04 (+1.51%)
DIS   176.97 (+0.55%)
PFE   43.77 (-0.39%)
BA   228.34 (+3.14%)
BAC   43.32 (+2.80%)
QQQ   368.40 (-1.32%)
AAPL   144.19 (-1.86%)
MSFT   294.31 (-1.68%)
FB   348.40 (-1.29%)
GOOGL   2,807.50 (-1.29%)
TSLA   771.90 (-0.32%)
AMZN   3,349.83 (-2.21%)
NVDA   214.43 (-2.89%)
BABA   145.36 (+0.19%)
NIO   34.91 (-1.33%)
CGC   14.14 (+1.65%)
GE   106.08 (+2.20%)
MU   74.45 (+0.54%)
AMD   103.83 (-1.86%)
T   27.47 (+1.25%)
F   14.13 (+2.54%)
ACB   6.04 (+1.51%)
DIS   176.97 (+0.55%)
PFE   43.77 (-0.39%)
BA   228.34 (+3.14%)
BAC   43.32 (+2.80%)
QQQ   368.40 (-1.32%)
AAPL   144.19 (-1.86%)
MSFT   294.31 (-1.68%)
FB   348.40 (-1.29%)
GOOGL   2,807.50 (-1.29%)
TSLA   771.90 (-0.32%)
AMZN   3,349.83 (-2.21%)
NVDA   214.43 (-2.89%)
BABA   145.36 (+0.19%)
NIO   34.91 (-1.33%)
CGC   14.14 (+1.65%)
GE   106.08 (+2.20%)
MU   74.45 (+0.54%)
AMD   103.83 (-1.86%)
T   27.47 (+1.25%)
F   14.13 (+2.54%)
ACB   6.04 (+1.51%)
DIS   176.97 (+0.55%)
PFE   43.77 (-0.39%)
BA   228.34 (+3.14%)
BAC   43.32 (+2.80%)
ASX:AVH

AVITA Medical Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume27.28 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive AVH News and Ratings via Email

Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter.


About AVITA Medical

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. is based in Valencia, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.21 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











AVITA Medical (ASX:AVH) Frequently Asked Questions

What stocks does MarketBeat like better than AVITA Medical?

Wall Street analysts have given AVITA Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AVITA Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were AVITA Medical's earnings last quarter?

AVITA Medical, Inc. (ASX:AVH) posted its earnings results on Thursday, February, 28th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by $0.01.
View AVITA Medical's earnings history
.

Who are AVITA Medical's key executives?

AVITA Medical's management team includes the following people:
  • Dr. Michael S. Perry D.V.M., DVM, Ph.D., FACVPT, CEO & Exec. Director (Age 62, Pay $1.88M)
  • Mr. Andrew Quick, Chief Technology Officer (Age 50, Pay $454.27k)
  • Ms. Donna Shiroma, Gen. Counsel & Sec. (Age 58, Pay $452.18k)
  • Ms. Erin Liberto, Chief Commercial Officer (Age 46, Pay $475.54k)
  • Mr. Michael Bria Holder, Chief Financial Officer (Age 58)
  • Mr. David Fencil, VP of Global Operations
  • Ms. Kathy M. McGee, Chief Operating Officer (Age 55)
  • Mr. Sean Ekins, Sr. VP of Fin. & Principal Accounting Officer
  • Ms. Debbie Garner, VP of Global Marketing

What other stocks do shareholders of AVITA Medical own?

What is AVITA Medical's stock symbol?

AVITA Medical trades on the ASX under the ticker symbol "AVH."

How much money does AVITA Medical make?

AVITA Medical has a market capitalization of $0.00 and generates $29.23 million in revenue each year.

How many employees does AVITA Medical have?

AVITA Medical employs 98 workers across the globe.

What is AVITA Medical's official website?

The official website for AVITA Medical is www.avitamedical.com.

Where are AVITA Medical's headquarters?

AVITA Medical is headquartered at IGRA Building, Panama City, Panama .

How can I contact AVITA Medical?

AVITA Medical's mailing address is IGRA Building, Panama City, Panama . The company can be reached via phone at 661-367-9170.


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.